Lite Strategy, Inc. Earnings Per Share, Basic and Diluted
Lite Strategy, Inc. (LITS) reported Earnings Per Share, Basic and Diluted of -$0.04 per share for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2019-11-07
- Lite Strategy, Inc. earnings per share, basic and diluted for the quarter ending 2019-09-30 was -$0.04.
- Lite Strategy, Inc. earnings per share, basic and diluted for the quarter ending 2018-09-30 was -$0.21.
- Lite Strategy, Inc. earnings per share, basic and diluted for the quarter ending 2016-09-30 was -$0.12.
- Lite Strategy, Inc. earnings per share, basic and diluted for the quarter ending 2016-06-30 was -$0.17.
- Lite Strategy, Inc. earnings per share, basic and diluted for fiscal 2016 was -$0.61.
- Lite Strategy, Inc. earnings per share, basic and diluted for fiscal 2015 was -$1.16.
- Lite Strategy, Inc. earnings per share, basic and diluted for fiscal 2014 was -$1.35.
- Lite Strategy, Inc. earnings per share, basic and diluted for fiscal 2013 was -$1.10.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-09-30 | -$0.04 10-Q · filed 2019-11-07 | |||||||
| 2018-09-30 | -$0.21 10-Q · filed 2019-11-07 | |||||||
| 2016-09-30 | -$0.12 10-Q · filed 2016-11-09 | |||||||
| 2016-06-30 | -$0.17 10-K · filed 2016-09-06 | -$0.61 10-K · filed 2016-09-06 | ||||||
| 2016-03-31 | -$0.16 10-K · filed 2016-09-06 | -$0.44 10-Q · filed 2016-05-05 | ||||||
| 2015-12-31 | -$0.15 10-K · filed 2016-09-06 | -$0.28 10-Q · filed 2016-02-05 | ||||||
| 2015-09-30 | -$0.13 10-Q · filed 2016-11-09 | |||||||
| 2015-06-30 | -$0.17 10-K · filed 2016-09-06 | -$1.16 10-K · filed 2016-09-06 | ||||||
| 2015-03-31 | -$0.27 10-K · filed 2016-09-06 | -$1.03 10-Q · filed 2016-05-05 | ||||||
| 2014-12-31 | -$0.39 10-K · filed 2016-09-06 | -$0.80 10-Q · filed 2016-02-05 | ||||||
| 2014-09-30 | -$0.42 10-K · filed 2016-09-06 | |||||||
| 2014-06-30 | -$0.40 10-K · filed 2015-09-02 | -$1.35 10-K · filed 2016-09-06 | ||||||
| 2014-03-31 | -$0.34 10-K · filed 2015-09-02 | -$0.95 10-Q · filed 2015-05-07 | ||||||
| 2013-12-31 | -$0.32 10-K · filed 2015-09-02 | -$0.60 10-Q · filed 2015-02-06 | ||||||
| 2013-09-30 | -$0.29 10-K · filed 2015-09-02 | |||||||
| 2013-06-30 | -$0.19 10-K · filed 2014-09-09 | -$1.10 10-K · filed 2015-09-02 | ||||||
| 2013-03-31 | -$0.18 10-K · filed 2014-09-09 | -$1.00 10-Q · filed 2014-05-08 | ||||||
| 2012-12-31 | -$0.50 10-K · filed 2014-09-09 | -$1.17 10-Q · filed 2014-02-11 | ||||||
| 2012-09-30 | -$0.70 10-K · filed 2014-09-09 | -$0.12 10-Q · filed 2012-11-13 | ||||||
| 2012-06-30 | -$0.71 10-K · filed 2013-09-18 | -$0.11 10-K · filed 2012-09-18 | -$3.35 10-K · filed 2014-09-09 | -$0.56 10-K · filed 2012-09-18 | ||||
| 2012-03-31 | -$0.93 10-K · filed 2013-09-18 | -$0.15 10-Q · filed 2012-05-15 | -$2.70 10-Q · filed 2013-05-09 | -$0.45 10-Q · filed 2012-05-15 | ||||
| 2011-12-31 | -$0.78 10-K · filed 2013-09-18 | -$0.13 10-Q · filed 2012-02-09 | -$1.76 10-Q · filed 2013-02-12 | -$0.29 10-Q · filed 2012-02-09 | ||||
| 2011-09-30 | -$1.01 10-K · filed 2013-09-18 | -$0.17 10-Q · filed 2011-11-14 | ||||||
| 2011-06-30 | -$0.19 10-K · filed 2012-09-18 | -$0.89 10-K · filed 2012-09-18 | ||||||
| 2011-03-31 | -$0.18 10-K · filed 2012-09-18 | -$0.70 10-Q · filed 2012-05-15 | ||||||
| 2010-12-31 | -$0.28 10-K · filed 2012-09-18 | -$0.52 10-Q · filed 2012-02-09 | ||||||
| 2010-09-30 | -$0.24 10-K · filed 2012-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |